ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: Lymphoma Foundation Offers Two-Year Fellowship Grants

July 31, 1998

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines

November 26, 1993

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002